#ThinkSabio Latest News
UPLIZNA® (INEBILIZUMAB-CDON) greatly enhances symptoms of generalized myasthenia gravis in patients with acetylcholine receptor autoantibodies over 52 weeks. AMGN
UPLIZNA® (INEBILIZUMAB-CDON) greatly enhances symptoms of generalized myasthenia gravis in patients with acetylcholine receptor autoantibodies over 52 weeks. AMGN